Pfizer 3Q Revenues: $12.6 billion (-2%) 3Q Earnings: $2.6 billion (-19%) YTD Revenues: $38.0 billion (-7%) YTD Earnings: $19.4 billion (earnings were $8.3 billion YTD13) Comments: Specialty Care revenues were $3.3 billion in the quarter, down 2%, primarily due to the shift in the reporting of Geodon and Revatio revenues in the U.S. and Xalabrands revenues (-23% to $140 million). Primary Care revenues were down 10% to $3.3 billion and Established Products sales were down 4% to $2.3 billion, ...